Nuvation Bio Inc. (NUVB)

USD 1.99

(5.59%)

Revenue Summary of Nuvation Bio Inc.

  • Nuvation Bio Inc.'s latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • Nuvation Bio Inc.'s latest quarterly revenue in 2024 Q2 was 1.43 Million USD , down 0.0% from previous quarter.
  • Nuvation Bio Inc. reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • Nuvation Bio Inc. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • Nuvation Bio Inc. reported a quarterly revenue of 1.43 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • Nuvation Bio Inc. reported a quarterly revenue of - USD for 2023 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of Nuvation Bio Inc. (2023 - 2018)

Historical Annual Revenue of Nuvation Bio Inc. (2023 - 2018)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%

Peer Revenue Comparison of Nuvation Bio Inc.

Name Revenue Revenue Difference
ADC Therapeutics SA 69.55 Million USD 100.0%
Alto Neuroscience, Inc. - USD NaN%
Annovis Bio, Inc. - USD NaN%
Biohaven Pharmaceutical Holding Company Ltd. - USD NaN%
Ginkgo Bioworks Holdings, Inc. 251.45 Million USD 100.0%
Nuvation Bio Inc. - USD NaN%
Arcus Biosciences, Inc. 117 Million USD 100.0%
Zymeworks Inc. 76.01 Million USD 100.0%